Purchase Order 75N92E26P00012
- Not listed
- This firm fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian federal agency, to the nonprofit research institution Jackson Laboratory in Bar Harbor, Maine. The $1,530,320.00 contract is for the development and supply of induced pluripotent stem cell (iPSC) lines for the NIA's Induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (INDI) project. The contract has no set-aside designation and is expected to be completed by July 31, 2026. Jackson...
- This is a $1,393,264.00 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Jackson Laboratory, a non-profit research organization located in Bar Harbor, Maine. The contract is for the provision of induced pluripotent stem cell (iPSC) lines for the NIA's Neurodegeneration Initiative project. The work will be performed in Bar Harbor, Maine and the contract has a period of performance through August 31, 2025. This contract is not set-aside....
- Jackson Laboratory has been awarded a $4.9 million firm fixed-price contract by the National Institutes of Health National Institute on Aging to deliver up to 414 isogenic induced pluripotent stem cell lines for the iPSC Neurodegeneration Initiative project. The three-year contract, running from September 2020 through September 2023, was awarded under a small business set-aside competitive solicitation seeking proposals to generate additional alleles to support the NIH Neurodegeneration...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $205,953 firm fixed-price purchase order to the Jackson Laboratory, a non-profit biomedical research institution, to generate a collection of engineered isogenic Alzheimer's diseases and related dementias (ADRD)-mutation induced pluripotent stem cell (iPSC) lines. The work was originally posted as a Sources Sought notice to identify qualified vendors, with no set-aside...
- This is a $6,006,560.00 Firm Fixed Price definitive contract awarded by the National Institute on Aging, a civilian agency, to The Jackson Laboratory, a non-profit organization, for IPSC Engineering Services. The contract has an ultimate completion date of September 19, 2025. The Jackson Laboratory is a non-profit biomedical research institution that specializes in mammalian genetics and genomics, providing research animals, husbandry services, molecular biology products, and other scientific...
- This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to the nonprofit Jackson Laboratory. The $586,788.54 firm-fixed-price contract has a completion date of December 31, 2020 and does not utilize any set-aside designation. As a nonprofit organization specializing in mammalian genetics and genomics, Jackson Laboratory has previously received numerous federal contract and grant...
- This is a firm fixed-price definitive contract awarded by the National Institute on Drug Abuse, a civilian agency, to the Jackson Laboratory, a nonprofit biomedical research institution, for the IPSC NEURODEGENERATION INITIATIVE (INDI) PROJECT. The contract has a ceiling value of $5,086,642.03 and a completion date of September 29, 2024. The contract does not have a set-aside designation. The Jackson Laboratory is a prime contractor that frequently partners with federal agencies, including the...
- This federal contract award from the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), was issued to The Jackson Laboratory, a nonprofit biomedical research institution. The $16,303.86 firm fixed-price purchase order is for other functions service to cryopreserve three mouse strains. The contract does not have a set-aside designation. The Jackson Laboratory has extensive experience providing specialized research animals,...
- The National Institute on Aging awarded a $20,527.53 firm fixed-price purchase order to The Jackson Laboratory for laboratory and testing services, with performance in Bar Harbor, Maine, and an ultimate completion date of May 31, 2022. The award was made on August 23, 2021, with no set-aside designation applied. Jackson Laboratory, a nonprofit biomedical research institution, is a premier provider of genetically engineered mouse models, specialized rodent strains, and associated research...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Jackson Laboratory, a nonprofit biomedical research organization. The $146,794 contract supports "TOLERABILITY AND AML STUDIES" research, with a period of performance ending on March 31, 2019. Jackson Laboratory has received numerous prior federal contract and grant awards from agencies...
The National Human Genome Research Institute awarded a $361,950 firm fixed-price purchase order to The Jackson Laboratory for induced pluripotent stem cell (iPSC) generation and beta cell differentiation services. The award, issued on February 13, 2026, with an ultimate completion date of February 12, 2027, supports the Institute's mission to advance human genome research through specialized cellular engineering capabilities. The work will be performed at Jackson Laboratory's facility in Bethesda, Maryland. No set-aside designation was applied to this contract award. Jackson Laboratory, a nonprofit biomedical research institution headquartered in Bar Harbor, Maine, is a premier federal contractor specializing in mammalian genetics, genomics, and the development of genetically engineered animal models. The organization holds four significant Indefinite Delivery Vehicles with federal agencies totaling over $261 million, including a $146.3 million contract with the National Institute of Allergy and Infectious Diseases through July 2031. Jackson Laboratory's extensive experience in iPSC development is evidenced by its $1.53 million purchase order from the National Institute on Aging for induced pluripotent stem cell lines supporting the Neurodegenerative Disease Initiative and its $6 million definitive contract from the same institute for iPSC engineering services. The laboratory serves as both a prime contractor and subcontractor across multiple NIH institutes and federal agencies, positioning it as a critical infrastructure resource for advancing translational medical research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $362.0k | 2/12/26 |